Hosted on MSN26d
RNA-targeting CRISPR reveals that hundreds of noncoding RNAs are essential—not 'junk'Now, a study in Cell finds that some noncoding RNAs are not, in fact, junk—they are functional and play an important role in ...
Medical Xpress on MSN13d
CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosisA new type of therapy that 'edits' a gene in patients with a rare heart condition has been shown to be safe and effective, according to research from UCL and the Royal Free Hospital.
When the CRISPR Cas9 protein is added to a cell along with a piece of guide RNA, the Cas9 protein hooks up with the guide RNA and then moves along the strands of DNA until it finds and binds to a ...
A single treatment with a CRISPR-Cas9 based gene editing therapy is enough to replace the daily medication of patients with ...
This expert work will continue as the CRISPR-Cas9 therapy NTLA-2002 moves into the third phase of the clinical development program. This trial will include more patients and once again be executed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback